Paul La Rosée

12PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)SociolinguisticsMedical biotechnology diagnostics (incl. biosensors)AutoimmunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 19, 2025
Treatment expectations and goals among patients with chronic myeloid leukemia in Germany: a patient-centered perspective.

Philipp Ernst, Cera Lohse, Michael Lauseker

|Jul 31, 2025
HLH: it is all about communication.

Rafal Machowicz, Paul La Rosée

|Nov 28, 2024
HLH: diagnostics revisited and improved.

Paul La Rosée, Felicitas La Rosée

|Jan 18, 2024
Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis.

Johanna Knauft, Thomas Schenk, Thomas Ernst

|Jul 28, 2023
The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial.

J Hammersen, S Birndt, K Döhner

|May 13, 2022
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial.

Andrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski

Pageof 2

Frequent Collaborators

4 joint publications

Felicitas La Rosée

3 joint publications

Sebastian Birndt

3 joint publications

Andreas Hochhaus

2 joint publications

P Reuken